Widely used:Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹19,486 Cr
P/E Ratio
31.66
P/B Ratio
5.02
Industry P/E
37.87
Debt to Equity
0
ROE
16.21 %
ROCE
22.37 %
Div. Yield
0.82 %
Book Value
847.79
EPS
134.55
CFO
₹3,247.49 Cr
EBITDA
₹5,793.94 Cr
Net Profit
₹4,325.78 Cr
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Pfizer
| -19.18 | 6.59 | -3.50 | 1.78 | -0.53 | -2.39 | 7.77 |
|
BSE Healthcare
| -6.54 | 1.91 | 4.84 | 19.10 | 20.06 | 22.35 | 10.14 |
|
BSE Mid Cap
| -6.88 | 4.00 | 4.54 | 3.86 | 20.61 | 29.80 | 15.34 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
Pfizer
| 23.76 | -3.67 | -12.34 | -4.24 | 20.72 | 47.12 | 39.46 |
|
BSE Mid Cap
| 25.84 | 45.53 | 1.38 | 39.18 | 19.87 | -3.05 | -13.31 |
|
BSE Healthcare
| 43.09 | 36.97 | -12.10 | 20.87 | 61.45 | -3.55 | -5.89 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | P/E Ratio | ROE |
|---|---|---|---|---|
| 30,100.00 | 63,948.39 | 47.92 | 36.97 | |
| 5,030.80 | 60,150.16 | 27.94 | 19.84 | |
| 318.85 | 38,275.13 | 47.59 | 3.88 | |
| 2,902.20 | 49,203.14 | 57.27 | 49.5 |
3 min read•By Markets Desk
3 min read•By Research Desk
2 min read•By Research Desk
Diversified Equity Funds: Not Dead Yet
4 min read•By Research Desk
Pfizer Limited engages in manufacturing, marketing, trading, and export of pharmaceutical products in India and internationally. The company offers its products in various therapeutic areas, including neuro/central nervous system, hormones,... cardiovascular, hemophilia, anti-infectives, gynecology, pain/analgesics, orthopedic, oncology, urology, anti-parasitic, gastro intestinal, vaccines, respiratory, and vitamins/minerals/nutrients. It sells its products through a network of independent distributors primarily under various brand names. The company was incorporated in 1950 and is headquartered in Mumbai, India. Read more
Incorporated
1950
Chairman
Pradip Shah
Managing Director
Meenakshi Nevatia
Group
Pfizer - MNC
Headquarters
Mumbai, Maharashtra
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Pfizer Ltd stood at ₹ 4,459 Cr as on 31-Dec-24
The share price of Pfizer Ltd is ₹4,268.40 (NSE) and ₹4,259.45 (BSE) as of 29-Apr-2025 IST. Pfizer Ltd has given a return of -0.53% in the last 3 years.
Pfizer Ltd has a market capitalisation of ₹ 19,486 Cr as on 29-Apr-2025. As per Value Research classification, it is a Mid Cap company.
The P/B ratio of Pfizer Ltd is 5.02 times as on 29-Apr-2025, a 1% discount to its peers’ median range of 5.06 times.
The P/E ratio of Pfizer Ltd is 31.66 times as on 29-Apr-2025, a 16% discount to its peers’ median range of 37.87 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Pfizer Ltd and enter the required number of quantities and click on buy to purchase the shares of Pfizer Ltd.
Pfizer Limited engages in manufacturing, marketing, trading, and export of pharmaceutical products in India and internationally. The company offers its products in various therapeutic areas, including neuro/central nervous system, hormones, cardiovascular, hemophilia, anti-infectives, gynecology, pain/analgesics, orthopedic, oncology, urology, anti-parasitic, gastro intestinal, vaccines, respiratory, and vitamins/minerals/nutrients. It sells its products through a network of independent distributors primarily under various brand names. The company was incorporated in 1950 and is headquartered in Mumbai, India.
The prominent promoters of Pfizer Ltd. are
| Name of promoters | Holding percentage |
|---|---|
|
PFIZER EAST INDIA B V |
39.75%
|
|
WYETH LLC |
12.28%
|
|
WYETH HOLDINGS CORPORATION |
3.56%
|
The chairman of the company is Pradip Shah, and the managing director is Meenakshi Nevatia.
There is no promoter pledging in Pfizer Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
63,212
|
|
|
60,210
|
|
|
47,502
|
|
|
37,459
|
| Pfizer Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
16.76
|
|
Operating margin(%)
|
28.8
|
|
Net Margin(%)
|
25.24
|
|
Dividend yield(%)
|
0.82
|
Yes, TTM profit after tax of Pfizer Ltd was ₹616 Cr.
₹-5.70
(
